English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/166700
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
DC FieldValueLanguage
dc.contributor.authorContreras, Laura-
dc.contributor.authorRial, Eduardo-
dc.contributor.authorCerdán, Sebastián-
dc.contributor.authorSatrústegui, Jorgina-
dc.identifierdoi: 10.1007/s11064-016-1999-5-
dc.identifierissn: 0364-3190-
dc.identifier.citationNeurochemical Research 42: 108- 114 (2017)-
dc.description.abstractThe mitochondrial aspartate/glutamate transporter Aralar/AGC1/Slc25a12 is critically involved in brain aspartate synthesis, and AGC1 deficiency results in a drastic fall of brain aspartate levels in humans and mice. It has recently been described that the uncoupling protein UCP2 transports four carbon metabolites including aspartate. Since UCP2 is expressed in several brain cell types and AGC1 is mainly neuronal, we set to test whether UCP2 could be a mitochondrial aspartate carrier in the brain glial compartment. The study of the cerebral metabolism of (1¿13C)-glucose in vivo in wild type and UCP2-knockout mice showed no differences in C3 or C2 labeling of aspartate, suggesting that UCP2 does not function as a mitochondrial aspartate carrier in brain. However, surprisingly, a clear decrease (of about 30¿35¿%) in the fractional enrichment of glutamate, glutamine and GABA was observed in the brains of UCP2-KO mice which was not associated with differences in either glucose or lactate enrichments. The results suggest that the dilution in the labeling of glutamate and its downstream metabolites could originate from the uptake of an unlabeled substrate that could not leave the matrix via UCP2 becoming trapped in the matrix. Understanding the nature of the unlabeled substrate and its precursor(s) as alternative substrates to glucose is of interest in the context of neurological diseases associated with UCP2.-
dc.description.sponsorshipS2010/BMD-2402 and SAF2014-56929R to JS, S2010/BMD-2349 and SAF2014-57739-R to SC, and S2010/BMD- 2402 and CSD2007-00020 to ER; and an institutional grant from Fundación Ramón Areces to the Centro de Biología Molecular Severo Ochoa -
dc.publisherKluwer Academic/Plenum Publishers-
dc.relation.isversionofPublisher's version-
dc.subjectCerebral metabolism-
dc.titleUncoupling Protein 2 (UCP2) Function in the Brain as Revealed by the Cerebral Metabolism of (1¿13C)-Glucose-
dc.description.versionPeer Reviewed-
dc.contributor.funderComunidad de Madrid-
dc.contributor.funderMinisterio de Economía y Competitividad (España)-
dc.contributor.funderFundación Ramón Areces-
Appears in Collections:(CBM) Artículos
Files in This Item:
File Description SizeFormat 
SatrusteguiJ_UncouplingProtein2(UCP).pdf1,28 MBAdobe PDFThumbnail
Show simple item record

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.